949: prognostic liver secretome signature and alpha-fetoprotein (plsec-afp) predicts long-term hepatocellular carcinoma risk in patients with cirrhosis: a nationwide phase 3 biomarker study in the u.s.
GASTROENTEROLOGY(2022)
Key words
prognostic liver secretome signature,hepatocellular carcinoma,cirrhosis,alpha-fetoprotein,plsec-afp,long-term
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined